Journal
PHARMACEUTICS
Volume 13, Issue 4, Pages -Publisher
MDPI
DOI: 10.3390/pharmaceutics13040512
Keywords
Moringa oleifera; protease; plant protease inhibitor; phytocystatin; papain inhibitor; antibacterial; anticoagulant; bioactive compound
Categories
Funding
- National Program of Natural and Traditional Medicine, Public Health Ministery, Cuba [1903016]
- Universidad Nacional de La Plata (Argentina) [PPID X/014, PPID X/038]
- National Agency of Scientific and Technological Promotion (Argentina) [PICT-2016-4365]
Ask authors/readers for more resources
In this study, the first phytocystatin MoPI isolated from Moringa oleifera was characterized for its potent inhibitory activity against cysteine proteases, antimicrobial activity against human pathogens, and anticoagulant activity. These findings highlight the pharmaceutical potential of this plant and its bioactive molecules.
Plant cystatins (or phytocystatins) comprise a large superfamily of natural bioactive small proteins that typically act as protein inhibitors of papain-like cysteine proteases. In this report, we present the purification and characterization of the first phytocystatin isolated from Moringa oleifera (MoPI). MoPI has a molecular mass of 19 kDa and showed an extraordinary physicochemical stability against acidic pHs and high temperatures. Our findings also revealed that MoPI is one of the most potent cysteine protease inhibitors reported to date, with Ki and IC50 values of 2.1 nM and 5.7 nM, respectively. More interestingly, MoPI presents a strong antimicrobial activity against human pathogens such as Enterococcus faecalis and Staphylococcus aureus. In addition, MoPI also showed important anticoagulant activity, which is an unprecedented property for this family of protease inhibitors. These results highlight the pharmaceutical potential of this plant and its derived bioactive molecules.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available